Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT06407336 |
Other study ID # |
MSRSW/Batch-Fall22/702 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
October 1, 2023 |
Est. completion date |
September 1, 2024 |
Study information
Verified date |
May 2024 |
Source |
Superior University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
the concept of spherical equivalent plays a pivotal role in simplifying the prescription and
enhancing communication between eye care professionals and patients. The spherical equivalent
is a calculated value that condenses the spherical and cylindrical components into a single
power.
Description:
Mathematically, it is determined by adding half of the cylindrical power to the spherical
power (SE = Sphere + (Cylinder/2)). This calculated value serves as a convenient
representation of the overall refractive error, aiding in a more straightforward
understanding of the prescription. Understanding their individual and collective impact on
contrast sensitivity opens up new avenues for refining corrective interventions and enhancing
the overall quality of vision. This article aims to demystify the intricate relationship
between spherical equivalent and cylindrical correction, and their collective impact on
contrast sensitivity.